GE Healthcare and Bernoulli Health working together to increase volume, fidelity and resolution of data captured from GE Healthcare monitors and other 3rd party medical devices
Milford, CT – November 14, 2017 – Bernoulli Health, the developer of the advanced Bernoulli One™ clinical surveillance, medical device integration (MDI), and real-time data analytics platform, announced today collaboration with GE Healthcare on the new CARESCAPE Connect data aggregation solution.
Interoperability enables informatics. The CARESCAPE Connect vision is to unlock data to enable outcomes research. To facilitate that vision, GE Healthcare and Bernoulli Health are working together to increase volume, fidelity and resolution of data captured from GE Healthcare monitors and other 3rd party medical devices; to build sources of data that are accessible to medical informaticists; and to enhance efficiency of data acquisition and storage into information repositories while lowering the barriers to integration.
“We’re working with Bernoulli Health because of their abilities to integrate diverse data sources as well as aggregating and normalizing in an IHE PCD DEC/ACM/WCM feed with the least compromise,” said GE Healthcare General Manager of Mobile Digital Health Pierre Delzac.
“We’re excited to collaborate with GE Healthcare to support researchers and data scientists by getting the richest data possible out of the CARESCAPE network, as well as other patient care devices, to provide comprehensive insight into the patient’s condition,” said Bernoulli Health CEO Janet Dillione.
About Bernoulli Health
The mission of Bernoulli® Health is to improve patient safety in real time. Since 1989, Bernoulli has developed solutions including the all-inclusive Bernoulli One™ platform. A single solution for continuous patient health monitoring and clinical surveillance, medical device integration, and real-time data analytics, there are no other solutions as advanced as Bernoulli One. The Bernoulli software helps save patient lives as it continuously detects deteriorating patient conditions and notifies clinicians of potential events. This results in improved patient observation and provider workflows. Bernoulli has achieved FDA Class II clearance for use in both patient monitoring and secondary alarm management. Bernoulli headquarters are in Milford, CT. For more information visit www.BernoulliHealth.com, email info@BernoulliHealth.com, or call 800-337-9936.
About GE Healthcare
GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter – great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients. For more information about GE Healthcare, visit our website at www.gehealthcare.com.